BCEIE › News › LALPATHLAB

Dividend

Dr. Lal Path Labs declares interim dividend of ₹5 per share

Dr. Lal Path Labs (LALPATHLAB) said its board has declared a interim dividend of ₹5 per equity share. The company is valued at about ₹32,282 crore.

BCEIE News Desk · Published 4 Nov 2026, 01:49 pm IST · Filing received 4 Nov 2026, 01:32 pm IST

What happened

In a filing with the NSE on 4 November 2026 at 01:32 PM, Dr. Lal Path Labs (LALPATHLAB) said that its board has declared a interim dividend of ₹5 per equity share.

From the filing: "Lal Path Labs Ltd. has informed the Exchange that Board of Directors at its meeting held on November 04, 2026, declared 2nd Interim Dividend of Rs. 5 per equity share."

How big is it?

At the latest price of ₹1,925.7, the ₹5 payout amounts to 0.26% of the share price.

Company snapshot

Dr. Lal Path Labs is a mid-cap company in the Healthcare sector, with a market value of about ₹32,282 crore.

The stock last traded at ₹1,925.7, against a 52-week range of ₹1,272.6–₹2,038.6 (5.5% below the high).

Before this filing the shares had moved −5.0% over the month and −0.7% over three months. Average daily turnover over the last 20 sessions was about ₹44.85 crore.

Promoters held 53.19% at the end of Q1 FY27, down 0.02% points from the previous quarter. Foreign institutions owned 17.36% and domestic institutions 21.59%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY26670132.415.88
Q2 FY26731150.618.05
Q3 FY2666090.55.42
Q4 FY26703131.37.86
Q1 FY27798169.510.15

What history shows

BCEIE's records show 3 previous dividend filings from the company since May 2026.

After those filings, the stock gained 3.0% on average the next trading day and was up 7.2% on average after five days (2 filings with price data).

Across 29 similar disclosures by other Healthcare companies, shares moved −1.0% on average the next day and −0.8% over five days; 38% of them rose the next day.

Market-wide, 980 dividend filings with an impact score of 50 or more saw an average next-day move of +0.0%, with 44% rising.

Past reactions describe what happened before; they are not a forecast.

Earlier filings of this kind
DateFilingNext day5 days
24 Jul 2026Dividend+8.3%+12.9%
17 Jul 2026Corporate Action-Board to consider Dividend−2.3%+1.5%

What to watch

  • 4 November 2026: Board meeting — Financial Results/Other business matters.
  • 4 November 2026: Board meeting — Dividend.

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.

More on Dr. Lal Path Labs Ltd.